ISB News

ISB K-12 Science Education Team Helps ‘STEM’ School Develop Curriculum

Riverpoint Academy in Spokane has been working with ISB’s K-12 science education team to develop curriculum that falls under “STEM” – science, technology, engineering and math. Riverpoint describes itself as a STEM school that also teaches arts, humanities and entrepreneurship. Some educators and administrators from Riverpoint and the Mead School District, as well as other community leaders visited ISB on May 3 and 4 to participate in a workshop to discuss how a signature project could be developed around personalized health. On May 21, students from Riverpoint Academy attended a panel featuring ISB scientists and then took a tour of the high-tech facilities. In April, Dr. Lee Hood, ISB president, traveled to Spokane to visit with students in the Mead District, including at Riverpoint Academy. Read the Spokesman Review’s story about the visit.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.